16 results
DEF 14A
SYRA
Syra Health Corp - Ordinary Shares
24 Apr 24
Definitive proxy
5:01pm
/Executive Director at Lilly Research Laboratories, at Lilly, where he led nonclinical safety and regulatory assessments on several cross functional … Safety Assessment (2004-2006); Senior Research Scientist, Nonclinical Safety Assessment (2000-2004); Research Scientist, Nonclinical Safety Assessment
10-K
2023 FY
SYRA
Syra Health Corp - Ordinary Shares
25 Mar 24
Annual report
3:01pm
merit.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER
10-Q
2023 Q3
SYRA
Syra Health Corp - Ordinary Shares
14 Nov 23
Quarterly report
12:00pm
, 2023.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION.
None.
ITEM 6
8-K
SYRA
Syra Health Corp - Ordinary Shares
4 Oct 23
Syra Health Corp. Announces Pricing of Upsized Initial Public Offering
4:45pm
as a Senior Researcher Advisor/Executive Director at Lilly Research Laboratories, at Lilly, where he led nonclinical safety and regulatory assessments … of Cancer Research, Nonclinical Safety Assessment (2004-2006); Senior Research Scientist, Nonclinical Safety Assessment (2000-2004); Research Scientist
424B4
bkl4e4yxzxopxbzqnh3a
3 Oct 23
Prospectus supplement with pricing info
6:10am
S-1/A
tzp1wx25k5ldgs8uy
12 Jun 23
IPO registration (amended)
9:05pm
S-1
EX-10.1
gzy4fqh3zu d442f6pin
3 May 23
IPO registration
9:34pm
S-1
9qflu6igl6qihmmptpnf
3 May 23
IPO registration
9:34pm
S-1
EX-10.13
g1ytihdpth3sb8s72ju
3 May 23
IPO registration
9:34pm
- Prev
- 1
- Next